Navigation Links
ESA in Medical News
ATLANTA, Dec. 10 /PRNewswire/ -- A new analysis presented today at the
American Society of Hematology (ASH) 49th Annual Meeting and Exposition
predicts that limiting the use of erythropoiesis-stimulating agents (ESAs)
for chemotherapy-induced anemia (CIA) would place considerable pressure on
t...
... their current regimen. According to the survey, the need for new phosphate binders and PTH modifiers is relatively high compared to the need for new esa and IV iron therapies. Particularly in the phosphate binder market, there are a number of important product attributes where current products fall sh...
...an's ability to make informed dosing decisions for esa and IV iron therapy. According to Dr. Van Wyc...oing dialysis." Over the course of the study, esa doses were held constant and IV iron therapy was w...Hb (Ret-H e or CHr) were useful analytes to guide esa and IV iron therapy, whereas ferritin and TSAT wer...
...timulating agents (ESAs) found that the cumulative esa cost with Epoetin alfa (EPO) was 29 percent lower ... current real-world dosing patterns and associated esa costs in an adult cancer chemotherapy population. The data showed that the cumulative esa cost was $4,321 for patients receiving EPO vs. $6,...
...orona detector instrument-control software driver. esa Biosciences, Inc., a Magellan Biosciences company ... labs, since so many have standardized on both the esa Corona and Waters platforms. Customers asked for i...ation, visit www.corona-ultra.com . About esa Life Science Tools ( www.esainc.com ) A Magella...
...Group, Inc. released TreatmentTrends(R): US Nephrology, a syndicated report based on online survey results from over 200 US Nephrologists. In the esa market, changes that have occurred seem to have taken place at the product level, while the overall use of ESAs has remained stable compared to the sa...
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
- Request Provides CMS with New Scientific Evidence - BRIDGEWATER, N.J., Nov. 8 /PRNewswire/ -- Ortho Biotech Products, L.P., the company that markets PROCRIT(R) (Epoetin alfa), today will formally request that the Centers for Medicare and Medicaid Services (CMS) reconsider its final ...Students from UAB and UPC will experiment under microgravity conditions at the ESA
A group of postgraduate students belonging to the Technical University of Catalonia (UPC) and Universitat Autnoma de Barcelona (UAB) were chosen by the European Space Agency (ESA) to design and carry out a scientific experiment under microgravity conditions. They will be monitoring how interactio...US Oncology Reports Second Quarter Operating Results
...risk management in this offering, as well as lower esa drug volumes. Pharmaceutical services EBITDA was ...ing criteria for reimbursement by Medicare for the esa usage issued on July 30, 2007. Unlike the NCD f...st, 2008. The REMS is expected to focus on future esa prescribing guidelines and may require additional ...... their current regimen. According to the survey, the need for new phosphate binders and PTH modifiers is relatively high compared to the need for new esa and IV iron therapies. Particularly in the phosphate binder market, there are a number of important product attributes where current products fall sh...
...an's ability to make informed dosing decisions for esa and IV iron therapy. According to Dr. Van Wyc...oing dialysis." Over the course of the study, esa doses were held constant and IV iron therapy was w...Hb (Ret-H e or CHr) were useful analytes to guide esa and IV iron therapy, whereas ferritin and TSAT wer...
SMOS ready to ship to launch site
...ns and preparations for the launch campaign. Following the final review, the Flight Acceptance Review Board, which comprised senior managers from esa and the French Space Agency CNES, were satisfied that all these elements are in good order and have signed the 'consent to ship' documentation. After ......timulating agents (ESAs) found that the cumulative esa cost with Epoetin alfa (EPO) was 29 percent lower ... current real-world dosing patterns and associated esa costs in an adult cancer chemotherapy population. The data showed that the cumulative esa cost was $4,321 for patients receiving EPO vs. $6,...
...orona detector instrument-control software driver. esa Biosciences, Inc., a Magellan Biosciences company ... labs, since so many have standardized on both the esa Corona and Waters platforms. Customers asked for i...ation, visit www.corona-ultra.com . About esa Life Science Tools ( www.esainc.com ) A Magella...
...Group, Inc. released TreatmentTrends(R): US Nephrology, a syndicated report based on online survey results from over 200 US Nephrologists. In the esa market, changes that have occurred seem to have taken place at the product level, while the overall use of ESAs has remained stable compared to the sa...
ESA in Medical Technology
BRIDGEWATER, N.J., May 16 /PRNewswire/ -- Data from three studies
evaluating associations between lower mean baseline hemoglobin (Hb) levels
and the rate of blood transfusions, as well as the possible effect of
restrictions on reimbursement for erythropoiesis-stimulating agents (ESAs)
in Medic...
...s a simple and cost-effective method for accurate, noninvasive, and continuous monitoring of fluid responsiveness. The three studies presented at the esa reinforce the accuracy of PVI compared to invasive measures and highlight its value for before, during, and after anesthesia. Does the Pleth Var...
...d with ESAs before and after implementation of the esa coverage limitations," said study director Chris L... and treated with ESAs after implementation of the esa NCD compared with before implementation of the esa NCD." Study Methods and Results D...
...reported that lower mean Hb levels achieved during esa therapy were associated with increased transfusion.... Another study of oncology patients who initiated esa therapy at different baseline Hb levels (Burton et... concluded that blood utilization was greater when esa therapy was initiated in patients who had baseline...
...d trials of ESAs to treat CIA. "The known risks of esa use are prominently displayed in the current produ...ch, along with independent investigators and other esa manufacturers, has provided data to the independen...tients, making it the largest combined analysis of esa safety data ever undertaken. The company also has ...
...icate that the presence of a lower hemoglobin when esa therapy was initiated was associated with a higher...eated oncology patients that received at least two esa doses. Results of the analysis were as follows: ...py-treated patients received transfusions when esa treatment was initiated at Hb levels below 10 ...
...s a simple and cost-effective method for accurate, noninvasive, and continuous monitoring of fluid responsiveness. The three studies presented at the esa reinforce the accuracy of PVI compared to invasive measures and highlight its value for before, during, and after anesthesia. Does the Pleth Var...
...d with ESAs before and after implementation of the esa coverage limitations," said study director Chris L... and treated with ESAs after implementation of the esa NCD compared with before implementation of the esa NCD." Study Methods and Results D...
New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
...nsistent with the risk observed in the erythropoiesis stimulating agent (ESA) class in general, known by Health Authorities and described in all esa labels. There was no difference in the incidence of serious (4% vs. 3%) or fatal TEEs (1% vs. 1%) for the NeoRecormon and control groups resp......reported that lower mean Hb levels achieved during esa therapy were associated with increased transfusion.... Another study of oncology patients who initiated esa therapy at different baseline Hb levels (Burton et... concluded that blood utilization was greater when esa therapy was initiated in patients who had baseline...
Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
...e group is about to generate important new analyses regarding the safety of esa use in CIA. The FDA should consider these analyses before making its final ...eased mortality observed in studies with high hemoglobin (Hb) targets. When esa use is targeted to Hb higher than 12 grams per deciliter of blood (g/dL), t......d trials of ESAs to treat CIA. "The known risks of esa use are prominently displayed in the current produ...ch, along with independent investigators and other esa manufacturers, has provided data to the independen...tients, making it the largest combined analysis of esa safety data ever undertaken. The company also has ...
...icate that the presence of a lower hemoglobin when esa therapy was initiated was associated with a higher...eated oncology patients that received at least two esa doses. Results of the analysis were as follows: ...py-treated patients received transfusions when esa treatment was initiated at Hb levels below 10 ...
PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
...n the Potential Impact on Blood Supply of Limiting esa Use for Chemotherapy Patients -- Poster: Impac... recent safety concerns from studies with another esa in cancer patients not receiving CT or RT, enr...tin alfa and darbepoetin alfa dosing patterns, esa treatment costs and red blood cell transfusion...Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
...fortunately, what FDA considers safe and effective esa use, CMS does not. As a result, our Medicare patie...e standard of care as our younger patients." The esa labeling revisions include additional warnings rel... CMS NCD, on the other hand, arbitrarily prohibits esa use when hemoglobin levels are 10 g/dL or higher. ...ESA in Biological News
Symposium to discuss geoengineering to fight climate change at the ESA Annual Meeting
Geoengineering techniques aim to slow global warming through the use of human-made changes to the Earth's land, seas or atmosphere. But new research shows that the use of geoengineering to do environmental good may cause other environmental harm. In a symposium at the Ecological Society of America...Sustainable agriculture at the ESA Annual Meeting
Advances in ecology increasingly reveal that conventional agricultural practices have detrimental effects on the landscape ecology, creating problems for long-term sustainability of crops. In a series of sessions at the Ecological Society of America's Annual Meeting, ecologists will present their ...Animal and plant communication at the ESA Annual Meeting
Animals and plants communicate with one another in a variety of ways: behavior, body patterns, and even chemistry. In a series of talks at the Ecological Society of America's annual meeting, to be held August 3-7 in Albuquerque, New Mexico, ecologists explore the myriad adaptations for exchanging ...Urban water ecology at the ESA annual meeting
Increasingly, human urban development overlaps with habitat for wild animals and plants, creating environments that degrade natural landscapes. But people, animals and plants all have in common the need for healthy, sustainable freshwater ecosystems. In a series of presentations at the Ecological ...Highlights from the March editions of ESA journals
The press tips below highlight research in the ESA journals Frontiers in Ecology and the Environment , Ecology , Ecological Applications and Ecological Monographs . 1. Fuel removal and prescribed burns reduce wildfire severity but may invite invasives Ecological Applications T...Almond pest management team to receive major award at ESA meeting
DAVIS--A University of California team that developed a successful insect pest management program for almond growers, leading to significant pesticide reduction, will be honored at the Entomological Society of America (ESA) annual meeting, Nov. 16-19 in Reno. The seven-member Almond Pest Mana...Colony collapse disorder symposium added to ESA Annual Meeting
Lanham, MD; October 17, 2007A late-breaking symposium, Colony Collapse Disorder in Honey Bees: Insight Into Status, Potential Causes, and Preventive Measures, has recently been added to the 55th Annual Meeting of the Entomological Society of America (ESA), to be held in San Diego, December 9-12. T...Wisconsin Governor Jim Doyle to receive Regional Policy Award from ESA
Gov. Jim Doyle will be the first recipient of a prestigious award given by the nation's largest group of ecologists at the 93rd Annual Meeting of the Ecological Society of America on August 3. The award recognizes a regional or local policymaker who has an outstanding record of informing their pol...Europe and China watching Earth together
...ongoing Dragon 2 research projects using data from esa and Chinese Earth observation satellites. Dragon 2 a joint undertaking between esa and the Ministry of Science and Technology (MOST) ...irst phase of Dragon developed the exploitation of esa EO data in China via joint projects led by Chinese...World Day to Combat Desertification focuses on human security
... essential to monitor the areas most at risk. esa has been working closely with the UNCCD secretaria...processes and their trends over time. In 2004, esa launched a large pilot project called DesertWatch ... used to satisfy UNCCD reporting requirements. esa is currently preparing an extension to DesertWatch...ESA in Biological Technology
..., visit www.dynextechnologies.com .
esa Life Sciences will feature its FDA-cleared test t...ficant improvements over other methodologies. The esa Biosciences Vitamin D Test , comprising reagent ki...ficity issues associated with existing assays. The esa test provides accurate and specific results as dem...
...ter of 2007 due to changes in foreign exchange which negatively impacted fourth quarter 2008 sales by approximately $12 million, pricing pressure, and esa (erythropoiesis stimulating agent) dosing conservatism in our oncology business. Excluding the impact of foreign exchange, worldwide product sales de...
...ntly leads the dialysis market and Ortho Biotech's Procrit and Amgen's Aranesp virtually split the CKD market. Even though the perceived need for new esa therapies is relatively low, ESAs with extended dosing intervals are desired in CKD and ESAs with less hemoglobin variability are desired in dialysis....
...is on the management of renal anemia and hyperphosphatemia. In the esa market, Amgen's Aranesp is the market share leader in both dialysis and CKD... differences between biosimilar ESAs and their reference brands. Projected esa share growth is most favorable for Roche's Mircera, particularly in France ...
..., lower target hemoglobin levels, lower levels for esa initiation, holds, and dose reductions) and more t...ephrologists do not predict significant changes in esa market share in CKD or dialysis in the near-term, ...ey do project that bundling will have an impact on esa use most likely through shifts to subcutaneous dos...
... very involved in monitoring lab values related to esa and IV iron use and making therapy decisions based..., the vast majority of Anemia Managers report that esa safety issues have impacted their use of ESAs in d...phrologists most often report protocol changes and esa dose reductions at lower hemoglobin levels as type...
... CHELMSFORD, Mass., Sept. 3 /PRNewswire/ -- esa Biosciences, a Magellan Biosciences company and le...-metabolite study. In these areas and many others, esa is making a substantial contribution to advance th... "The Frost & Sullivan Innovation Award comes as esa is completing metabolomics work made possible by a...
...t of Stage 3 and Stage 4 CKD patients treated with ESAs compared to the previous year. And, approximately one-third of Nephrologists report that their esa use has decreased specifically due to managed care policies. While there have been no significant changes in market share year over year (Amgen's Epog...
...ter of 2007 due to changes in foreign exchange which negatively impacted fourth quarter 2008 sales by approximately $12 million, pricing pressure, and esa (erythropoiesis stimulating agent) dosing conservatism in our oncology business. Excluding the impact of foreign exchange, worldwide product sales de...
...ntly leads the dialysis market and Ortho Biotech's Procrit and Amgen's Aranesp virtually split the CKD market. Even though the perceived need for new esa therapies is relatively low, ESAs with extended dosing intervals are desired in CKD and ESAs with less hemoglobin variability are desired in dialysis....
...is on the management of renal anemia and hyperphosphatemia. In the esa market, Amgen's Aranesp is the market share leader in both dialysis and CKD... differences between biosimilar ESAs and their reference brands. Projected esa share growth is most favorable for Roche's Mircera, particularly in France ...
..., lower target hemoglobin levels, lower levels for esa initiation, holds, and dose reductions) and more t...ephrologists do not predict significant changes in esa market share in CKD or dialysis in the near-term, ...ey do project that bundling will have an impact on esa use most likely through shifts to subcutaneous dos...
Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
... changes in foreign exchange which positively impacted third quarter 2008 sales by approximately $35 million, partially offset by pricing pressure and esa (erythropoiesis stimulating agent) dosing conservatism versus the prior year. Excluding the impact of foreign exchange, international product sales de...... very involved in monitoring lab values related to esa and IV iron use and making therapy decisions based..., the vast majority of Anemia Managers report that esa safety issues have impacted their use of ESAs in d...phrologists most often report protocol changes and esa dose reductions at lower hemoglobin levels as type...
... CHELMSFORD, Mass., Sept. 3 /PRNewswire/ -- esa Biosciences, a Magellan Biosciences company and le...-metabolite study. In these areas and many others, esa is making a substantial contribution to advance th... "The Frost & Sullivan Innovation Award comes as esa is completing metabolomics work made possible by a...
NPL to create 'encyclopedia for space nanomaterials'
... she explains. The NPL led consortium will help esa to identify nanomaterials companies with potential...tium's report is due in August 2009. It will allow esa to review potential applications of nanomaterials ...nos Stavrinidis, Head of Mechanical Engineering at esa explained that NPL won the contract for its long s......t of Stage 3 and Stage 4 CKD patients treated with ESAs compared to the previous year. And, approximately one-third of Nephrologists report that their esa use has decreased specifically due to managed care policies. While there have been no significant changes in market share year over year (Amgen's Epog...
Other TagsOther Contents
GoldfieldsReddysCathetersSuperintendentMRPsMinorsIntenionalClaimantsPsychoticOverstretchedAtheromasoutpacesbeggarcookie
(Date:6/19/2013)... (PRWEB) June 19, 2013 Blueforce ... and sensor machine software, today announced it has ... its Decentralized Fusion Engine technology. The award ... the acquisition of key strategic partnerships. , ... wireless collaboration and machine-to-machine (M2M) software products that ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... 19, 2013 Walkingspree, a specialized wellness ... the launch of its new Facebook App. This is ... inspire participants to reach their program fitness goals. Consistent ... Walkingspree clients are given more tools to customize their ... , Corporate clients may choose whether or not they ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
Breaking Medicine News(10 mins):Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Stealth Grow Tent Brand’s Popularity Rises 2[0] Blueforce Awarded Patent for Decentralized Sensor Fusion[0] Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist[0] Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement[0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns[0] Stealth Grow Tent Brand’s Popularity Rises
(Date:6/18/2013)... Scientists at the University of Calgary,s Faculty of Medicine ... the body from harmful bacteria. Platelets, a component of ... search for specific bacteria, and upon detection, seal it ... which were published in Nature Immunology this ... of immunity. , "The science community has known that ...
(Date:6/18/2013)... a hacker lab. At Brandeis University, sophisticated computational ... helping scientists understand the complex interplay between genomic ... virus, outer "shell" critical for replication. ... we are finding will help researchers alter virus ... fellow Jason Perlmutter, first author of the scientific ...
(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Computer modeling technique goes viral at Brandeis 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |